NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lindus Health

Lindus Health

Private
LondonHealthcare & Life Scienceshttps://lindushealth.com/

Last Round

Series B

Jan 21, 2025

Total Funding Raised

$79.54M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lindus Health is a healthcare technology company that provides comprehensive solutions for conducting clinical trials, including access to electronic health records, patient recruitment, data capture, and project management, all aimed at enhancing trial efficiency and patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Medical AI, Patient Engagement

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROclinical trial managementpatient recruitmentAI-powered clinical trialsclinical trial softwaretech-enabled CROdigital clinical trialseClinical platformpatient enrollmentclinical trial automationvirtual clinical trialsdecentralized clinical trialsDCTclinical trial designbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lindus Health Comparables

Compare Lindus Health with similar companies based on industry and business-model similarity.

Lindus Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vial
87%
ObvioHealth
82%
Curebase
80%

Lindus Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 21, 2025
Series AAug 16, 2023
GrantMay 17, 2023
SeedDec 1, 2022
SeedNov 5, 2021

Key People

Founding team and executive leadership

Michael Young

Co-CEO

Executive Team

Nik Haldimann

CTO

Executive Team

Gemma Harrison

Chief Product and Technology Officer

Executive Team

Lindus Health Investors

Notable investors and investment history

Lindus Health investors
InvestorRounds
Innovate UKGrant
Salica InvestmentsSeed, Series A
Firstminute CapitalSeries B, Series A, Seed
CreandumSeries B, Series A
Visionaries ClubSeries B
Amino CollectiveSeed, Series A
Presight CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Heather Davis joins as US VP of Clinical Operations.

  • Apr 1, 2026

    Launched Lindus Therapeutics (LTx) to build a portfolio of clinical-stage assets.

Lindus Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lindus Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lindus Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range218
Year Founded2021
Last FundingJan 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.